Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than ...

For decades, so many families have watched loved ones suffer from Huntington's disease, a neurodegenerative condition that progressively worsens over time. But now, there is finally a light at the end ...

By Michael Erman and Puyaan Singh March 5 (Reuters) - A senior FDA official called UniQure's experimental treatment for ...

Add Yahoo as a preferred source to see more of our stories on Google. Huntington’s disease is a progressive brain disorder caused by a defective gene (Alamy/PA) Scientists have slowed the progression ...

For the first time, scientists have successfully treated someone suffering from Huntington's disease, a fatal genetic illness ...

Gene therapy is becoming a powerful way to treat challenging diseases that don’t respond to traditional treatments, and researchers now report the first success in modifying genes to slow Huntington’s ...

Doctors have announced the first successful treatment for Huntington’s disease, a devastating inherited condition that combines symptoms of dementia, Parkinson’s and motor neurone disease. The ...

uniQure's AMT-130 receives Breakthrough Therapy designation from FDA for Huntington's disease, based on promising clinical trial data. uniQure N.V. announced that the U.S. FDA has granted Breakthrough ...

(CNN) - There may be some hope for those living with Huntington’s disease after a new experimental gene therapy was reportedly found to slow the progression of the disease. Drugmaker Uniqure announced ...

Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...

UniQure needs to run another trial to prove its gene therapy "actually helps people with Huntington's disease," said a senior FDA official.